NEUROTOUCH

USPTO USPTO 2000 ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark NEUROTOUCH was filed as Word mark on 06/22/2000 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".

Trademark Details Last update: August 2, 2019

Trademark form Word mark
File reference 76075418
Application date June 22, 2000

Trademark owner

Chivers Way, Histon
Cambridge CB4 4ZR
GB

Trademark representatives

goods and services

5 Drugs for the management of pain and related conditions; pain control drugs; drugs for the treatment of neurodegeneractive diseases and neurological and psychiatric disorders; drugs affecting psychological and motor performance; drugs for use in connection with drug abuse; analgesics; and ion channel modulators
9 Computer hardware; experimental apparatus and instrumentation, and computer software and hardware for cognitive, psychological and neuropsychological testing; cognition and neuropsychological testing systems employing visual tests displayed on a computer screen for testing humans and animals; scientific and laboratory apparatus and instruments for electrophysiology applications; computer software controlling cognitive psychological and neuropsychological testing apparatus, scientific and laboratory apparatus and instruments for electrophysiology applications, and operant chambers for animal testing; database management software and electronic databases in the field of cognitive, psychological, and neuropsychological testing recorded on computer media; clinical assessment software, hardware, experimental apparatus, and instrumentation; touch screen apparatus for all the aforesaid; and parts and fittings for all the aforesaid
10 Apparatus and instruments for cognitive, psychological, and neuropsychological testing, diagnosis, and treatment; medical apparatus and instruments, namely, screening instrumentation for electrophysiological testing; operant chambers for animal testing; and parts and fittings for all the aforesaid
42 Biotechnology research and development; neurological, pharmaceutical, and genetic research and development; drug discovery, design, and research and development; research and development relating to ion channel modulators, neuradegenerative diseases, analgesics and pain control; neuropsychological and diagnostic testing, research, and development; consultancy services relating to all the aforesaid

ID: 1376075418